Mir-18a inhibits CDC42 and plays a tumour suppressor role in colorectal cancer cells

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Humphreys, Karen J ^a   McKinnon, Ross A ^a   Michael, Michael Z ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 18A; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN CDC42; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN18A MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CANCER GROWTH; CDC42 GENE; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; COLORECTAL CANCER; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; GENE FUNCTION; GENE REPRESSION; GENE TARGETING; HCT116 CELL LINE; HUMAN; HUMAN TISSUE; SIGNAL TRANSDUCTION; COLON; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; RECTUM; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; CDC42 GTP-BINDING PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; COLON; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; RECTUM;

EID: 84911445892     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112288     Document Type: Article

References (57)

1. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, et al. (2006) The colorectal microRNAome. Proc Natl Acad Sci USA 103: 3687-3692.
2. Hutvagner G, Zamore PD (2002) A microRNA in a multiple-turnover RNAi enzyme complex. Science 297: 2056-2060.
3. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114.
4. Guo H, Ingolia NT, Weissman JS, Bartel DP (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840.
5. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
6. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, et al. (2006) Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20: 2202-2207.
7. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, et al. (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72: 397-402.
8. Guil S, Esteller M (2009) DNA methylomes, histone codes and miRNAs: tying it all together. Int J Biochem Cell Biol 41: 87-95.
9. Mendell JT, Olson EN (2012) MicroRNAs in stress signaling and human disease. Cell 148: 1172-1187.
10. Medina PP, Nolde M, Slack FJ (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467: 86-90.
11. Mu P, Han YC, Betel D, Yao E, Squatrito M, et al. (2009) Genetic dissection of the miR-17,92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 23: 2806-2811.
12. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, et al. (2009) miR-19 is a key oncogenic component of mir-17-92. Genes Dev 23: 2839-2849.
13. Jin HY, Oda H, Lai M, Skalsky RL, Bethel K, et al. (2013) MicroRNA-17,92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways. EMBO J 32: 2377-2391.
14. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
15. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, et al. (2004) Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64: 3087-3095.
16. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261.
17. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, Mongera S, Postma C, et al. (2009) MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 101: 707-714.
18. Kahlert C, Klupp F, Brand K, Lasitschka F, Diederichs S, et al. (2011) Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases. Cancer Sci 102: 1799-1807.
19. Yu G, Tang JQ, Tian ML, Li H, Wang X, et al. (2012) Prognostic values of the miR-17-92 cluster and its paralogs in colon cancer. J Surg Oncol 106: 232-237.
20. Humphreys KJ, Cobiac L, Le Leu RK, Van der Hoek MB, Michael MZ (2013) Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster. Mol Carcinog 52: 459-474.
21. Guil S, Caceres JF (2007) The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nat Struct Mol Biol 14: 591-596.
22. Chaulk SG, Thede GL, Kent OA, Xu Z, Gesner E, et al. (2011) Role of primiRNA tertiary structure in miR-17,92 miRNA biogenesis. RNA Biol 8: 1105-1114.
23. Chakraborty S, Mehtab S, Patwardhan A, Krishnan Y (2012) Pri-miR-17-92a transcript folds into a tertiary structure and autoregulates its processing. Rna 18: 1014-1028.
24. Muller PY, Janovjak H, Miserez AR, Dobbie Z (2002) Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32: 1372-1374, 1376, 1378-1379.
25. Chen HY, Yang YM, Stevens BM, Noble M (2013) Inhibition of redox/Fyn/c- Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells. EMBO Mol Med 5: 723-736.
26. Hong L, Kenney SR, Phillips GK, Simpson D, Schroeder CE, et al. (2013) Characterization of a Cdc42 protein inhibitor and its use as a molecular probe. J Biol Chem 288: 8531-8543.
27. Dweep H, Sticht C, Pandey P, Gretz N (2011) miRWalk-database: prediction of possible miRNA binding sites by ''walking'' the genes of three genomes. J Biomed Inform 44: 839-847.
28. Mariadason JM, Corner GA, Augenlicht LH (2000) Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res 60: 4561-4572.
29. Iacomino G, Tecce MF, Grimaldi C, Tosto M, Russo GL (2001) Transcriptional response of a human colon adenocarcinoma cell line to sodium butyrate. Biochem Biophys Res Commun 285: 1280-1289.
30. Daly K, Shirazi-Beechey SP (2006) Microarray analysis of butyrate regulated genes in colonic epithelial cells. DNA Cell Biol 25: 49-62.
31. Ellenbroek SI, Collard JG (2007) Rho GTPases: functions and association with cancer. Clin Exp Metastasis 24: 657-672.
32. Reymond N, Im JH, Garg R, Vega FM, Borda d9Agua B, et al. (2012) Cdc42 promotes transendothelial migration of cancer cells through beta1 integrin. J Cell Biol 199: 653-668.
33. Stengel KR, Zheng Y (2012) Essential role of Cdc42 in Ras-induced transformation revealed by gene targeting. PLoS One 7: e37317.
34. Nobes CD, Hall A (1995) Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81: 53-62.
35. Rohatgi R, Ma L, Miki H, Lopez M, Kirchhausen T, et al. (1999) The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell 97: 221-231.
36. Olson MF, Ashworth A, Hall A (1995) An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269: 1270-1272.
37. Fukata M, Watanabe T, Noritake J, Nakagawa M, Yamaga M, et al. (2002) Rac1 and Cdc42 capture microtubules through IQGAP1 and CLIP-170. Cell 109: 873-885.
38. Gomez Del Pulgar T, Valdes-Mora F, Bandres E, Perez-Palacios R, Espina C, et al. (2008) Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism. Int J Oncol 33: 185-193.
39. Marques CA, Hahnel PS, Wolfel C, Thaler S, Huber C, et al. (2008) An immune escape screen reveals Cdc42 as regulator of cancer susceptibility to lymphocyte-mediated tumor suppression. Blood 111: 1413-1419.
40. Sakamori R, Yu S, Zhang X, Hoffman A, Sun J, et al. (2014) CDC42 inhibition suppresses progression of incipient intestinal tumors. Cancer Res.
41. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL (2011) Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11: 558-572.
42. Olive V, Sabio E, Bennett MJ, De Jong CS, Biton A, et al. (2013) A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis. Elife 2: e00822.
43. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A 105: 1608-1613.
44. Carlin LM, Evans R, Milewicz H, Fernandes L, Matthews DR, et al. (2011) A targeted siRNA screen identifies regulators of Cdc42 activity at the natural killer cell immunological synapse. Sci Signal 4: ra81.
45. Rao E, Jiang C, Ji M, Huang X, Iqbal J, et al. (2012) The miRNA-17,92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. Leukemia 26: 1064-1072.
46. Kang SG, Liu WH, Lu P, Jin HY, Lim HW, et al. (2013) MicroRNAs of the miR-17,92 family are critical regulators of T(FH) differentiation. Nat Immunol 14: 849-857.
47. Pothula S, Bazan HE, Chandrasekher G (2013) Regulation of Cdc42 expression and signaling is critical for promoting corneal epithelial wound healing. Invest Ophthalmol Vis Sci 54: 5343-5352.
48. Park SY, Lee JH, Ha M, Nam JW, Kim VN (2009) miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol 16: 23-29.
49. Ma J, Xue Y, Liu W, Yue C, Bi F, et al. (2013) Role of activated rac1/cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer. PLoS One 8: e66275.
50. Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, et al. (2013) Treatment of HCV infection by targeting microRNA. N Engl J Med 368: 1685-1694.
51. Pullamsetti SS, Doebele C, Fischer A, Savai R, Kojonazarov B, et al. (2012) Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension. Am J Respir Crit Care Med 185: 409-419.
52. Bader AG (2012) miR-34 - a microRNA replacement therapy is headed to the clinic. Front Genet 3: 120.
53. Fujiya M, Konishi H, Mohamed Kamel MK, Ueno N, Inaba Y, et al. (2013) microRNA-18a induces apoptosis in colon cancer cells via the autophagolysosomal degradation of oncogenic heterogeneous nuclear ribonucleoprotein A1. Oncogene.
54. Tao J, Wu D, Li P, Xu B, Lu Q, et al. (2012) microRNA-18a, a member of the oncogenic miR-17-92 cluster, targets Dicer and suppresses cell proliferation in bladder cancer T24 cells. Mol Med Report 5: 167-172.
55. Dar AA, Majid S, Rittsteuer C, de Semir D, Bezrookove V, et al. (2013) The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. J Natl Cancer Inst 105: 433-442.
56. Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, et al. (2009) The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci U S A 106: 15732-15737.
57. Luo Z, Dai Y, Zhang L, Jiang C, Li Z, et al. (2013) miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Carcinogenesis 34: 415-425.